Institutional Ownership Nls Pharmaceutics LTD Wt Pur C (NLSPW)
This table provides information about the institutional ownership of Nls Pharmaceutics LTD Wt Pur C (NLSPW). We have compiled data on the 9 institutions that hold shares in the stock, with a total of 1.15 Million shares, which have been reported (via 13F filing form) to have a value of $57,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Armistice Capital, LLC
New York, NY |
May 15, 2024 Q1 2024 |
500,000
shares
|
$25,000
0.0% of portfolio
|
Q2 2023
Reduced -0.0%
|
|
|
Altium Capital Management LP
New York, NY |
May 15, 2024 Q1 2024 |
200,000
shares
|
$10,000
0.01% of portfolio
|
Q4 2021
New holding
|
|
|
Ayrton Capital LLC
Westport, CT |
Nov 13, 2023 Q3 2023 |
170,100
shares
|
$8,505
0.64% of portfolio
|
Q4 2021
New holding
|
|
|
Empery Asset Management, LP
New York, NY |
Nov 14, 2022 Q3 2022 |
150,000
shares
|
$7,500
0.23% of portfolio
|
Q1 2022
New holding
|
|
|
Hudson Bay Capital Management LP
Greenwich, CT |
May 15, 2024 Q1 2024 |
100,000
shares
|
$5,000
0.0% of portfolio
|
Q1 2022
Reduced 50.0%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
May 07, 2024 Q1 2024 |
12,548
shares
|
$627
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Clear Street LLC
|
May 13, 2024 Q1 2024 |
8,577
shares
|
$428
0.0% of portfolio
|
Q1 2024
Added 0.91%
|
|
|
Ubs Group Ag
|
May 13, 2024 Q1 2024 |
6,023
shares
|
$301
0.0% of portfolio
|
Q1 2024
Added 502.3%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Apr 30, 2024 Q1 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q1 2024
New holding
|